ADVANCE for Respiratory Care and Sleep Medicine

12/14/2020

Join us at Elite for Your Coronavirus Update for December 10, part of our ongoing series aimed at keeping you informed about COVID-19.

10/07/2020

Your Coronavirus Update for October 5; stay up to date with Elite. More than 35.4 million cases of coronavirus (COVID-19) have been diagnosed worldwide as of Sunday evening, including at least 1.4 million deaths. Healthcare officials in the United States have reported more than 7.4 million positive....

10/07/2020

Children who have bronchitis at least once before the age of 7 years are more likely to develop lung problems in later life, according to a study presented at the European Respiratory Society International Congress 2020, held virtually from Sept. 7 to 9.

Jennifer Perret, PhD, from the University of Melbourne in Australia, and colleagues assessed the relationship between childhood bronchitis and clinical outcomes in middle age using data from the Tasmanian Longitudinal Health Study (3,085 people; 1968 to 2016). Parent-reported bronchitis by age 7 years was categorized as none (reference), nonrecurrent, recurrent, and recurrent-protracted. Respiratory outcomes assessed at age 53 years included chronic bronchitis, asthma, and pre/postbronchodilator spirometry.

If you would like to read more, please follow the link below:

Australian researcher looks at over 3,000 cases Children who have bronchitis at least once before the age of 7 years are more likely to develop lung problems in later life, according to a study presented at the European Respiratory Society International Congress 2020, held virtually from Sept. 7 to....

10/07/2020

Cannabinoids, a class of prescription pills that contain synthetically-made chemicals found in ma*****na, are associated with a 64 percent increase in death among older adults with chronic obstructive pulmonary disease (COPD), according to the first published data on the impact of cannabinoids on the respiratory health of individuals with the lung disease.

The findings, published Wednesday in Thorax, have significant clinical implications as more physicians prescribe cannabinoids to patients with COPD to treat chronic muscle pain, difficulty sleeping and breathlessness.

If you would like to know more, please follow the link below:

Findings recently published following Canadian study Cannabinoids, a class of prescription pills that contain synthetically-made chemicals found in ma*****na, are associated with a 64 percent increase in death among older adults with chronic obstructive pulmonary disease (COPD), according to the fir...